← Open Payments lookup

LACIE THEIS: Open Payments

NPI 1871105916 · WAVERLY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,622 in 167 payments from 15 companies in 2025. Trend: 2023 $1,811 · 2024 $2,021 · 2025 $2,622

Food & beverage: $2,399Education: $223
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.52$428
Teva Pharmaceuticals USA, Inc.16$427
Otsuka America Pharmaceutical, Inc.14$241
Alkermes, Inc.14$210
ABBVIE INC.12$202
E.R. Squibb & Sons, L.L.C.11$202
Axsome Therapeutics, Inc.6$177
Janssen Pharmaceuticals, Inc10$173
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$172
Supernus Pharmaceuticals, Inc.12$145

Products named: INGREZZA, VRAYLAR, COBENFY, ARISTADA, REXULTI, Auvelity, INVEGA SUSTENNA, CAPLYTA.

Industry payments across IA — which companies pay providers there.